News

ECHAlliance Group Capability Statement is now available!

ECHAlliance Group Capability Statement is now available!
Events, Global Health Connector Partnership
Projects

We are delighted to launch the ECHAlliance Group Capability Statement where you will find an overview of our capabilities, experience, qualifications, achievements and be able to understand what we do.

As our company continues to expand, it becomes increasingly important to clearly articulate our offerings and expertise. Over the past years, we have undergone significant growth and expanded our services and global presence. To reflect this, we have created a comprehensive summary of our capabilities.
As you may be aware, our strategy can be summarised in four words: Connect, Convene, Amplify, and Accelerate. Our dynamic Capability Statement now supports and illustrates these concepts. We believe that this document will provide you with a comprehensive overview of the scale and scope of our capabilities.
We sincerely hope that you enjoy reading this document. You may be surprised by the scale of what we do. 

Brian O’Connor, Chair at ECHAlliance Group

NEWS​

Related News

Finland – Kuopio Health Ecosystem is ECHAlliance Ecosystem of the Month – July

15 Jul 2024
This month we are featuring our Finland - Kuopio Health Ecosystem as our Ecosystem of the Month.

EU JAMRAI- 2: Building a One Health World

15 Jul 2024
The mission at EU-JAMRAI 2 is to lead the fight against antimicrobial resistance (AMR) through joint and coordinated action across Europe.

Team MediBoost Wins AI4Health.Cro Innovation Competition

15 Jul 2024
Team MediBoost clinched the top prize at this year’s AI4Health.Cro innovation competition, winning €5,000 for their groundbreaking application designe...

Tackling obesity

8 Jul 2024
Apply for funding to develop effective strategies to tackle overweight and obesity. ‘Tackling obesity’ is open to applications submitted to the Popula...

Cancer research transatlantic development and skills enhancement award 2024

4 Jul 2024
Following the UK-US Cancer Summit, MRC and NIHR, in partnership with NCI, are launching a second competition for the cancer research transatlantic dev...

24/52 Liver Disease (EME Programme)

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *